Acamprosate (Campral ®)
- thought to reduce drinking by modulating the brain GABA and glutamate function, which is implicated in withdrawal symptoms
- only reaches desired levels in the brain after 1-2 weeks
- appears to be effective in maintaining abstinence from alcohol following withdrawal in dependent drinkers
Treatment Availability
Indications (when treatment might be suitable)
Contraindications (when treatment will not be suitable)
Effects & mechanism of action
Potential side effects & risks (including overdose)
Ceasing or withdrawing from treatment
Further Resources
